Fluence Analytics, a Pioneer in Digitalizing the Monitoring of Polymerization Reaction Processes, Acquired by Yokogawa

Yokogawa Electric Corporation announced the acquisition of Fluence Analytics, Inc., a US-based startup that provides real-time analytics solutions to polymer and biopharmaceutical companies worldwide. Since signing investment and collaboration agreements in August 2021, the two companies have been exploring potential business opportunities. Through this acquisition, Fluence Analytics will integrate its operations with Yokogawa’s existing business and further enhance its technological capabilities. Fluence Analytics will operate as Yokogawa Fluence Analytics from now on.

Fluence Analytics is a global leader in polymerization reaction monitoring and control, and its automatic continuous online monitoring of polymerizations (ACOMP) product is the only commercially available system that can measure and analyze multiple polymer properties in real time. ACOMP’s data streams provide new insights into material properties that enable customers to optimize and control polymerization processes, leading to improved product quality, greater yields, and less energy consumption and material waste. Based on the average size of a polymer reactor, the ACOMP system is estimated to deliver US$1.5 million in value per year, estimated by Fluence Analytics based on the following operating conditions: Annual production 15,000 tons (300 batches/year, 50 tons per batch), USD 3,000 per ton.

Initial agreements between the two companies in August 2021 generated strong interest from global chemical companies seeking to transform their operations with automated digital technologies. Fluence Analytics is currently developing the next-generation ACOMP product, which will become part of Yokogawa’s OpreX offering. The two companies are exploring how to integrate the next-generation ACOMP with Yokogawa’s advanced control solutions and the digital technologies of KBC, another Yokogawa Group company. Yokogawa’s global network will perform engineering and system integration tasks and provide after-sales field services for the ACOMP system.

In addition to ACOMP, the Fluence Analytics product portfolio includes a lab instrument designed to accelerate and optimize the development of novel biotherapeutics. The instrument enables the rapid assessment and real-time monitoring of the stability of therapeutic proteins, peptides, and other biopolymers under various thermal, mechanical, and chemical stress conditions.